<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 13, 2000
--------------
Pharmaprint Inc.
--------------------
(Exact name of registrant as specified in charter)
<TABLE>
<S> <C> <C>
Delaware 33-0640125
-------- ---------------------- ----------
(State or other jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number)
</TABLE>
2600 Michelson Drive, Suite 1600, Irvine, Ca 92612
-------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (949) 794-7778
--------------
<PAGE>
ITEM 5. OTHER EVENTS
On April 13, 2000, PharmaPrint Inc. ("PharmaPrint") announced that C.
Richard Piazza, Chairman and Chief Executive Officer of PharmaPrint tendered his
resignation, effective as of April 14, 2000. Mr. Piazza has agreed to act as a
consultant to PharmaPrint to manage the day-to-day operations of the Company.
The Board of Directors of PharmaPrint will begin searching immediately to find
interim and permanent replacements.
-2-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHARMAPRINT INC.
Date: April 13, 2000 By: /s/ Phillip G. Trad
---------------------
Phillip G. Trad
Director
-3-
